The DOI matches its Crossref record; 131 of the 131 references it cites were found in a registry or an index.
Adenosine as a Multi-Signalling Guardian Angel in Human Diseases: When, Where and How Does it Exert its Protective Effects?
Open accessAbstract
The importance of adenosine for human health cannot be overstated. Indeed, this ubiquitous nucleoside is an integral component of ATP, and regulates the function of every tissue and organ in the body. Acting via receptor-dependent and -independent mechanisms [the former mediated via four G-protein-coupled receptors (GPCRs), A1, A2A, A2B, and A3,], it has a significant role in protecting against cell damage in areas of increased tissue metabolism, and combating organ dysfunction in numerous pathological states. Accordingly, raised levels of adenosine have been demonstrated in epilepsy, ischaemia, pain, inflammation, and cancer, in which its behaviour can be likened to that of a guardian angel, even though there are instances in which overproduction of adenosine is pathological. In this review, we condense the current body of knowledge on the issue, highlighting when, where, and how adenosine exerts its protective effects in both the brain and the periphery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
4 retracted
Hart, M. L., Grenz, A., Gorzolla, I. C., Schittenhelm, J., Dalton, J. H., & Eltzschig, H. K. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.0903617 · Cited by 121
RetractedHart, M. L., Gorzolla, I. C., Schittenhelm, J., Dalton, J. H., & Eltzschig, H. K. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700997 · Cited by 116
RetractedGrenz, A., Bauerle, J. D., Dalton, J. H., Ridyard, D. G., Badulak, A., Tak, E., McNamee, E. N., Clambey, E. T., Moldovan, R., Reyes, G., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci60214 · Cited by 106
RetractedZimmerman, M. A., Grenz, A., Tak, E., Kaplan, M., Ridyard, D. G., Brodsky, K. S., Mandell, M. S., Kam, I., & Eltzschig, H. K. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1221733110 · Cited by 34
RetractedOhta, A., & Sitkovsky, M. (2001) · Nature · doi:10.1038/414916a · Cited by 1,334
Fredholm, B. B., IJzerman, A. P., Jacobson, K. A., Linden, J., & Müller, C. E. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003285 · Cited by 1,301
Adenosine A1 receptors mediate local anti-nociceptive effects of acupuncture
Goldman, N., Chen, M., Fujita, T., Xu, Q., Peng, W., Liu, W., Jensen, T. K., Pei, Y., Wang, F., Han, X., et al. (2010) · Nature Neuroscience · doi:10.1038/nn.2562 · Cited by 807
Immunity, inflammation and cancer: a leading role for adenosine
Antonioli, L., Blandizzi, C., Pacher, P., & Haskó, G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3613 · Cited by 765
Methotrexate—how does it really work?
Chan, E. S. L., & Cronstein, B. N. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.5 · Cited by 459
Mechanisms of action of methotrexate
Genestier, L., Paillot, R., Quemeneur, L., Izeradjene, K., & Revillard, J.-P. (2000) · Immunopharmacology · doi:10.1016/s0162-3109(00)00189-2 · Cited by 424
Ferrante, C. J., Pinhal-Enfield, G., Elson, G., Cronstein, B. N., Hasko, G., Outram, S., & Leibovich, S. J. (2013) · Inflammation · doi:10.1007/s10753-013-9621-3 · Cited by 375
Regulation of Inflammation by Adenosine
Haskó, G., & Cronstein, B. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00085 · Cited by 367
Extracellular Adenosine-Mediated Modulation of Regulatory T Cells
Ohta, A., & Sitkovsky, M. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00304 · Cited by 320
Eckle, T., Hartmann, K., Bonney, S., Reithel, S., Mittelbronn, M., Walker, L. A., Lowes, B. D., Han, J., Borchers, C. H., Buttrick, P. M., et al. (2012) · Nature Medicine · doi:10.1038/nm.2728 · Cited by 314
Adenosine Kinase: Exploitation for Therapeutic Gain
Boison, D. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.006361 · Cited by 310
A ketogenic diet suppresses seizures in mice through adenosine A1 receptors
Masino, S. A., Li, T., Theofilas, P., Sandau, U. S., Ruskin, D. N., Fredholm, B. B., Geiger, J. D., Aronica, E., & Boison, D. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57813 · Cited by 308
Epigenetic changes induced by adenosine augmentation therapy prevent epileptogenesis
Williams-Karnesky, R. L., Sandau, U. S., Lusardi, T. A., Lytle, N. K., Farrell, J. M., Pritchard, E. M., Kaplan, D. L., & Boison, D. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65636 · Cited by 266
Regulation of Neutrophil Function by Adenosine
Barletta, K. E., Ley, K., & Mehrad, B. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.226845 · Cited by 260
The A3 Adenosine Receptor: History and Perspectives
Borea, P. A., Varani, K., Vincenzi, F., Baraldi, P. G., Tabrizi, M. A., Merighi, S., & Gessi, S. (2015) · Pharmacological Reviews · doi:10.1124/pr.113.008540 · Cited by 244
Self-citationKhoa, N. D., Montesinos, M. C., Reiss, A. B., Delano, D., Awadallah, N., & Cronstein, B. N. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.7.4026 · Cited by 234
Adenosine in Tissue Protection and Tissue Regeneration
Linden, J. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.011783 · Cited by 234
Gomes, C., Ferreira, R., George, J., Sanches, R., Rodrigues, D. I., Gonçalves, N., & Cunha, R. A. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-16 · Cited by 233
Resolution Pharmacology: Opportunities for Therapeutic Innovation in Inflammation
Perretti, M., Leroy, X., Bland, E. J., & Montero-Melendez, T. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.07.007 · Cited by 227
Pharmacological and therapeutic effects of A3 adenosine receptor agonists
Fishman, P., Bar-Yehuda, S., Liang, B. T., & Jacobson, K. A. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2011.10.007 · Cited by 227
The A3 adenosine receptor: An enigmatic player in cell biology
Gessi, S., Merighi, S., Varani, K., Leung, E., Mac Lennan, S., & Borea, P. A. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.09.002 · Cited by 224
Self-citationAdenosine receptors and cancer
Gessi, S., Merighi, S., Sacchetto, V., Simioni, C., & Borea, P. A. (2011) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2010.09.020 · Cited by 224
Self-citationRegulation of Macrophage Function by Adenosine
Haskó, G., & Pacher, P. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.226852 · Cited by 223
Sitkovsky, M. V., Hatfield, S., Abbott, R., Belikoff, B., Lukashev, D., & Ohta, A. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0075 · Cited by 215
Adenosine receptor targets for pain
Sawynok, J. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2015.10.031 · Cited by 199
Signaling through the A2B Adenosine Receptor Dampens Endotoxin-Induced Acute Lung Injury
Schingnitz, U., Hartmann, K., MacManus, C. F., Eckle, T., Zug, S., Colgan, S. P., & Eltzschig, H. K. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903035 · Cited by 183
Pain-relieving prospects for adenosine receptors and ectonucleotidases
Zylka, M. J. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.12.006 · Cited by 172
Adenosine Receptors and Cancer
Fishman, P., Bar‐Yehuda, S., Synowitz, M., Powell, J. D., Klotz, K., Gessi, S., & Borea, P. A. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-89615-9_14 · Cited by 161
Self-citationThe resurgence of A2B adenosine receptor signaling
Aherne, C. M., Kewley, E. M., & Eltzschig, H. K. (2011) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2010.05.016 · Cited by 159
Gharibi, B., Abraham, A. A., Ham, J., & Evans, B. A. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.424 · Cited by 159
Ketogenic diet prevents epileptogenesis and disease progression in adult mice and rats
Lusardi, T. A., Akula, K. K., Coffman, S. Q., Ruskin, D. N., Masino, S. A., & Boison, D. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.08.007 · Cited by 155
Regulation of Lymphocyte Function by Adenosine
Linden, J. M., & Cekic, C. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.226837 · Cited by 155
Carroll, S. H., Wigner, N. A., Kulkarni, N. N., Johnston‐Cox, H., Gerstenfeld, L. C., & Ravid, K. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.344994 · Cited by 154
Adenosine and inflammation: what's new on the horizon?
Antonioli, L., Csóka, B., Fornai, M., Colucci, R., Kókai, E., Blandizzi, C., & Haskó, G. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.02.010 · Cited by 154
Endogenous adenosine A3 receptor activation selectively alleviates persistent pain states
Little, J. W., Ford, A., Symons-Liguori, A. M., Chen, Z., Janes, K., Doyle, T. M., Xie, J. Y., Luongo, L., Tosh, D. K., Maione, S., et al. (2014) · Brain · doi:10.1093/brain/awu330 · Cited by 150
Dendritic cells tolerized with adenosine A2AR agonist attenuate acute kidney injury
Li, L., Huang, L., Ye, H., Song, S., Bajwa, A., Lee, S. J., Moser, E. K., Jaworska, K., Kinsey, G. R., Day, Y., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63170 · Cited by 149
Peres, R. S., Liew, F. Y., Talbot, J., Carregaro, V., de Oliveira, R. D. R., Almeida, S. C. L., França, R. F. D. O., Donate, P. B., Pinto, L. G., Ferreira, F. I. S., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1424792112 · Cited by 145
Adenosinergic signaling in epilepsy
Boison, D. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.08.046 · Cited by 144
Adenosine—a physiological or pathophysiological agent?
Fredholm, B. B. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-013-1101-6 · Cited by 140
Varani, K., J, M. P. J., Vincenzi, F., Targa, M., Trotta, F., Govoni, M., & Borea, P. A. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3527 · Cited by 139
Self-citationAdenosine Receptor-Mediated Cardioprotection
McIntosh, V. J., & Lasley, R. D. (2011) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248410396877 · Cited by 136
Niccoli, G., Rigattieri, S., Vita, M. R. D., Valgimigli, M., Corvo, P., Fabbiocchi, F., Romagnoli, E., Caterina, A. R. D., Torre, G. L., Schiavo, P. L., et al. (2013) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2013.02.009 · Cited by 135
Janes, K., Wahlman, C., Little, J. W., Doyle, T. M., Tosh, D. K., Jacobson, K. A., & Salvemini, D. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.08.010 · Cited by 134
Vincenzi, F., Targa, M., Corciulo, C., Gessi, S., Merighi, S., Setti, S., Cadossi, R., Goldring, M. B., Borea, P. A., & Varani, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065561 · Cited by 133
Self-citationMediero, A., & Cronstein, B. N. (2013) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2013.02.001 · Cited by 133
Poth, J. M., Brodsky, K. S., Ehrentraut, H., Grenz, A., & Eltzschig, H. K. (2012) · Journal of Molecular Medicine · doi:10.1007/s00109-012-0988-7 · Cited by 125
CD73‐generated adenosine promotes osteoblast differentiation
Takedachi, M., Oohara, H., Smith, B. J., Iyama, M., Kobashi, M., Maeda, K., Long, C. L., Humphrey, M. B., Stoecker, B. J., Toyosawa, S., et al. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.23001 · Cited by 125
Flögel, U., Burghoff, S., van Lent, P. L. E. M., Temme, S., Galbarz, L., Ding, Z., El‐Tayeb, A., Hüls, S., Bönner, F., Borg, N., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003717 · Cited by 122
Attenuating myocardial ischemia by targeting A2B adenosine receptors
Eltzschig, H. K., Bonney, S. K., & Eckle, T. D. L. G. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.02.005 · Cited by 117
A2B Adenosine Receptor Gene Deletion Attenuates Murine Colitis
Kolachala, V. L., Vijay–Kumar, M., Dalmasso, G., Yang, D., Linden, J. M., Wang, L., Gewirtz, A. T., Ravid, K., Merlin, D., & Sitaraman, S. V. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.05.049 · Cited by 113
Janes, K., Esposito, E., Doyle, T. M., Cuzzocrea, S., Tosh, D. K., Jacobson, K. A., & Salvemini, D. (2014) · Pain · doi:10.1016/j.pain.2014.09.016 · Cited by 112
The A1 adenosine receptor as a new player in microglia physiology
Luongo, L., Guida, F., Imperatore, R., Napolitano, F., Gatta, L., Cristino, L., Giordano, C. S. D. S., Siniscalco, D., Marzo, V. D., Bellini, G., et al. (2013) · Glia · doi:10.1002/glia.22592 · Cited by 108
Controlling murine and rat chronic pain through A 3 adenosine receptor activation
Chen, Z., Janes, K., Chen, C., Doyle, T. M., Bryant, L., Tosh, D. K., Jacobson, K. A., & Salvemini, D. (2012) · The FASEB Journal · doi:10.1096/fj.11-201541 · Cited by 107
Theofilas, P., Brar, S. K., Stewart, K.-A., Shen, H., Sandau, U. S., Poulsen, D. J., & Boison, D. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2010.02947.x · Cited by 105
Mediero, A., Wilder, T., Perez‐Aso, M., & Cronstein, B. N. (2015) · The FASEB Journal · doi:10.1096/fj.14-265066 · Cited by 103
The emerging role of DNA methylation in epileptogenesis
Kobow, K., & Blümcke, I. (2012) · Epilepsia · doi:10.1111/epi.12031 · Cited by 101
Extracellular Adenosine: A Safety Signal That Dampens Hypoxia-Induced Inflammation During Ischemia
Grenz, A., Homann, D., & Eltzschig, H. K. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3665 · Cited by 100
Aherne, C. M., Saeedi, B. J., Collins, C. B., Masterson, J. C., McNamee, E. N., Perrenoud, L., Rapp, C., Curtis, V. F., Bayless, A., Fletcher, A., et al. (2015) · Mucosal Immunology · doi:10.1038/mi.2015.22 · Cited by 99
Comorbidities in Neurology: Is adenosine the common link?
Boison, D., & Aronica, E. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.04.031 · Cited by 97
Johnston‐Cox, H., & Ravid, K. (2011) · Purinergic Signalling · doi:10.1007/s11302-011-9220-4 · Cited by 95
David, M., Akerman, L., Ziv, M., Kadurina, M., Gospodinov, D. K., Pavlotsky, F., Yankova, R. K., Kouzeva, V., Ramon, M., Silverman, M. H., et al. (2011) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2011.04078.x · Cited by 94
Mediero, A., Perez‐Aso, M., & Cronstein, B. N. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12227 · Cited by 93
CF102 for the Treatment of Hepatocellular Carcinoma: A Phase I/II, Open-Label, Dose-Escalation Study
Stemmer, S. M., Benjaminov, O., Medalia, G., Ciuraru, N. B., Silverman, M. H., Bar‐Yehuda, S., Fishman, S., Harpaz, Z., Farbstein, M., Cohen, S., et al. (2012) · The Oncologist · doi:10.1634/theoncologist.2012-0211 · Cited by 93
Alveolar Epithelial A2B Adenosine Receptors in Pulmonary Protection during Acute Lung Injury
Hoegl, S., Brodsky, K. S., Blackburn, M. R., Karmouty‐Quintana, H., Zwißler, B., & Eltzschig, H. K. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401957 · Cited by 89
Ford, A., Castonguay, A., Cottet, M., Little, J. W., Chen, Z., Symons-Liguori, A. M., Doyle, T. M., Egan, T. M., Vanderah, T. W., Koninck, Y. D., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.4495-14.2015 · Cited by 89
Ntantie, E., Gonyo, P., Lorimer, E., Hauser, A. D., Schuld, N. J., McAllister, D. M., Kalyanaraman, B., Dwinell, M. B., Auchampach, J. A., & Williams, C. L. (2013) · Science Signaling · doi:10.1126/scisignal.2003374 · Cited by 87
Adenosine A 2A Receptor Activation Prevents Wear Particle–Induced Osteolysis
Mediero, A., Frenkel, S. R., Wilder, T., He, W., Mazumder, A., & Cronstein, B. N. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003393 · Cited by 87
Adenosine receptor targeting in health and disease
Gessi, S., Merighi, S., Fazzi, D., Stefanelli, A., Varani, K., & Borea, P. A. (2011) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2011.627853 · Cited by 84
Self-citationGessi, S., Fogli, E., Sacchetto, V., Merighi, S., Varani, K., Preti, D., Leung, E., MacLennan, S., & Borea, P. A. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.194902 · Cited by 81
Self-citationSquadrito, F., Bitto, A., Altavilla, D., Arcoraci, V., Caridi, G. D., Feo, M. E. D., Corrao, S., Pallio, G., Sterrantino, C., Minutoli, L., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3569 · Cited by 80
Adenosine A2A Receptors Modulate Acute Injury and Neuroinflammation in Brain Ischemia
Pedata, F., Pugliese, A. M., Coppi, E., Dettori, I., Maraula, G., Cellai, L., & Melani, A. (2014) · Mediators of Inflammation · doi:10.1155/2014/805198 · Cited by 80
Mazzon, E., Esposito, E., Impellizzeri, D., Paola, R. D., Melani, A., Bramanti, P., Pedata, F., & Cuzzocrea, S. (2011) · The Journal of Rheumatology · doi:10.3899/jrheum.110111 · Cited by 75
Du, X., Ou, X., Song, T., Zhang, W., Cong, F., Zhang, S., & Xiong, Y. (2015) · Experimental Biology and Medicine · doi:10.1177/1535370215584939 · Cited by 74
He, W., Mazumder, A., Wilder, T., & Cronstein, B. N. (2013) · The FASEB Journal · doi:10.1096/fj.13-231233 · Cited by 74
Adenosine Receptors and Epilepsy
Masino, S. A., Kawamura, M., & Ruskin, D. N. (2014) · International review of neurobiology · doi:10.1016/b978-0-12-801022-8.00011-8 · Cited by 74
Chen, Z., Xiong, C., Pancyr, C., Stockwell, J., Walz, W., & Cayabyab, F. S. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.3991-13.2014 · Cited by 72
Purinergic signaling in scarring
Ferrari, D., Gambari, R., Idzko, M., Müller, T., Albanesi, C., Pastore, S., Manna, G. L., Robson, S. C., & Cronstein, B. N. (2015) · The FASEB Journal · doi:10.1096/fj.15-274563 · Cited by 71
Sowa, N. A., Street, S. E., Vihko, P., & Zylka, M. J. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.2162-10.2010 · Cited by 69
Fordyce, C. B., Gersh, B. J., Stone, G. W., & Granger, C. B. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.06.004 · Cited by 66
Vincenzi, F., Targa, M., Romagnoli, R., Merighi, S., Gessi, S., Baraldi, P. G., Borea, P. A., & Varani, K. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.01.028 · Cited by 66
Self-citationActivation of A1, A2A, or A3 adenosine receptors attenuates lung ischemia-reperfusion injury
Gazoni, L. M., Walters, D. M., Unger, E. B., Linden, J. M., Kron, I. L., & Laubach, V. E. (2010) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2010.03.002 · Cited by 63
Purines and neuronal excitability: Links to the ketogenic diet
Masino, S. A., Kawamura, M., Ruskin, D. N., Geiger, J. D., & Boison, D. (2011) · Epilepsy Research · doi:10.1016/j.eplepsyres.2011.07.014 · Cited by 59
Identification of A3adenosine receptor agonists as novel non‐narcotic analgesics
Janes, K., Symons-Liguori, A. M., Jacobson, K. A., & Salvemini, D. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13446 · Cited by 59
Gessi, S., Merighi, S., Stefanelli, A., Fazzi, D., Varani, K., & Borea, P. A. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2013.08.002 · Cited by 57
Self-citationThe hypoxia–inflammation link and potential drug targets
Koeppen, M., Eckle, T. D. L. G., & Eltzschig, H. K. (2011) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0b013e32834873fd · Cited by 54
Loram, L. C., Taylor, F. R., Strand, K. A., Harrison, J. A., Lynn, R. R., Sholar, P. W., Rieger, J. M., Maier, S. F., & Watkins, L. R. (2013) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2013.06.004 · Cited by 54
Ge, Z., van der Hoeven, D., Maas, J. E., Wan, T. C., & Auchampach, J. A. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.01.018 · Cited by 52
Cheong, S. L., Federico, S., Venkatesan, G., Mandel, A. L., Shao, Y. M., Moro, S., Spalluto, G., & Pastorin, G. (2011) · Medicinal Research Reviews · doi:10.1002/med.20254 · Cited by 48
A2a and a2b adenosine receptors affect HIF‐1α signaling in activated primary microglial cells
Merighi, S., Borea, P. A., Stefanelli, A., Bencivenni, S., Castillo, C. A., Varani, K., & Gessi, S. (2015) · Glia · doi:10.1002/glia.22861 · Cited by 46
Self-citationImlach, W. L., Bhola, R. F., May, L. T., Christopoulos, A., & Christie, M. J. (2015) · Molecular Pharmacology · doi:10.1124/mol.115.099499 · Cited by 44
do Nascimento, F. P., Macedo-Júnior, S. J., Pamplona, F. A., Cerutti, M. L., Córdova, M. M., Constantino, L. C., Tasca, C. I., Dutra, R. C., Calixto, J. Β., Reid, A. R., et al. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8815-5 · Cited by 43
Adenosine receptors and diabetes: Focus on the A2B adenosine receptor subtype
Merighi, S., Borea, P. A., & Gessi, S. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.06.015 · Cited by 42
Self-citationVarani, K., Vincenzi, F., Targa, M., et al. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.06.005 · Cited by 42
Self-citationSawynok, J., & Reid, A. R. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.10.036 · Cited by 41
Protective effects of pentoxifylline in pulmonary inflammation are adenosine receptor A 2A dependent
Konrad, F. M., Neudeck, G., Vollmer, I., Ngamsri, K., Thiel, M., & Reutershan, J. (2013) · The FASEB Journal · doi:10.1096/fj.13-228122 · Cited by 41
Romagnoli, R., BARALDI, P. G., Tabrizi, M. A., Gessi, S., Borea, P. A., & Merighi, S. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710792927831 · Cited by 40
Self-citationDifferential Tissue-Specific Function of Adora2b in Cardioprotection
Seo, S.-W., Koeppen, M., Bonney, S. K., Gobel, M., Thayer, M., Harter, P. N., Ravid, K., Eltzschig, H. K., Mittelbronn, M. G. A., Walker, L. A., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402288 · Cited by 39
Chhabra, P., Linden, J. M., Lobo, P. I., Okusa, M. D., & Brayman, K. L. (2012) · Current Diabetes Reviews · doi:10.2174/157339912803529878 · Cited by 38
Intrathecal clonidine and adenosine
Rauck, R. L., North, J. M., & Eisenach, J. C. (2015) · Pain · doi:10.1016/j.pain.0000000000000007 · Cited by 38
Sawynok, J., Reid, A. R., & Liu, J. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.07.012 · Cited by 37
Hussain, A., Gharanei, A. M., Nagra, A. S., & Maddock, H. L. (2013) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-013-6500-y · Cited by 36
Hargus, N. J., Jennings, C., Perez‐Reyes, E., Bertram, E. H., & Patel, M. K. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2011.03337.x · Cited by 34
Mandili, G., Alchera, E., Merlin, S., Imarisio, C., Chandrashekar, B. R., Riganti, C., Bianchi, A., Novelli, F., Follenzi, A., & Carini, R. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.10.007 · Cited by 33
Role of JunB in Adenosine A2B Receptor–Mediated Vascular Endothelial Growth Factor Production
Ryzhov, S. V., Biktasova, A., Goldstein, A. E., Zhang, Q., Biaggioni, I., Dikov, M. M., & Feoktistov, I. (2013) · Molecular Pharmacology · doi:10.1124/mol.113.088567 · Cited by 33
Du, L., Gao, Z.-G., Nithipatikom, K., IJzerman, A. P., van Veldhoven, J. P. D., Jacobson, K. A., Gross, G. J., & Auchampach, J. A. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.187559 · Cited by 33
Ciruela, F., Fernández‐Dueñas, V., Llorente, J., Borroto‐Escuela, D. O., Cuffí, M. L., Carbonell, L., Sánchez, S., Agnati, L. F., Fuxé, K., & Tasca, C. I. (2012) · Brain Research · doi:10.1016/j.brainres.2012.04.056 · Cited by 32
Adenosine A2A Receptor and TNF-α Regulate the Circadian Machinery of the Human Monocytic THP-1 Cells
Pérez‐Aso, M., Feig, J. L., Aránzazu, M., & Cronstein, B. N. (2012) · Inflammation · doi:10.1007/s10753-012-9530-x · Cited by 32
Ryzhov, S. V., Goldstein, A. E., Novitskiy, S. V., Blackburn, M. R., Biaggioni, I., & Feoktistov, I. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.190835 · Cited by 30
On the Role of Dendritic Cells Versus Other Cells in Inducing Protective CD8+ T Cell Responses
Zinkernagel, R. M. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00030 · Cited by 27
León, D., Albasanz, J. L., & Martı́n, M. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13130 · Cited by 27
Montesinos, M. C., Desai, A., & Cronstein, B. N. (2015) · Inflammation · doi:10.1007/s10753-015-0184-3 · Cited by 26
Arasa, J., Martos, P., Terencio, M. C., Valcuende, F., & Montesinos, M. C. (2014) · Experimental Dermatology · doi:10.1111/exd.12461 · Cited by 25
Design and application of locally delivered agonists of the adenosine A2Areceptor
Mantell, S. J., Jones, R., & Trevethick, M. (2009) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.09.57 · Cited by 24
Rudich, N., Dekel, O., & Sagi‐Eisenberg, R. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2014.12.015 · Cited by 24
Wan, T. C., Tosh, D. K., Du, L., Gizewski, E. T., Jacobson, K. A., & Auchampach, J. A. (2011) · BMC Pharmacology · doi:10.1186/1471-2210-11-11 · Cited by 24
Ryzhov, S. V., Sung, B. H., Zhang, Q., Weaver, A. M., Gumina, R. J., Biaggioni, I., & Feoktistov, I. (2014) · Purinergic Signalling · doi:10.1007/s11302-014-9410-y · Cited by 22
Ren, W., Tu, W., Jiang, S., Cheng, R., & Du, Y. (2012) · Europe PMC (PubMed Central) · doi:10.3969/j.issn.1673-5374.2012.33.007 · Cited by 19
Nazir, S. A., Khan, J. N., Mahmoud, I. Z., Greenwood, J. P., Blackman, D. J., Kunadian, V., Been, M., Abrams, K. R., Wilcox, R. G., Adgey, A. J., et al. (2014) · Trials · doi:10.1186/1745-6215-15-371 · Cited by 18
Tian, Y., Marshall, M. A., French, B. A., Linden, J. M., & Yang, Z. (2015) · Basic Research in Cardiology · doi:10.1007/s00395-015-0473-x · Cited by 16
Constantino, L. C., Pamplona, F. A., MATHEUS, F. C., Ludka, F. K., Gómez‐Soler, M., Ciruela, F., Boeck, C. R., Prediger, R. D., & Tasca, C. I. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.12.056 · Cited by 15
Adenosine kinase is a new therapeutic target to prevent ischemic neuronal death.
Boison, D., & Shen, H. (2010) · PubMed · Cited by 15
Ryzhov, S. V., Zhang, Q., Biaggioni, I., & Feoktistov, I. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.05.012 · Cited by 15
Targeting adenosine receptors to prevent inflammatory skin diseases
Gessi, S., Merighi, S., & Borea, P. A. (2014) · Experimental Dermatology · doi:10.1111/exd.12474 · Cited by 14
Self-citationWen, W., Ren, R., Wenzhan, Ту, Songhe, S., Jiang, Rui-dong, Cheng, Yaping, & Du (2012) · 中国神经再生研究:英文版 · Cited by 13
A2BAR expression in non-immune cells plays an important role in the development of murine colitis
Ingersoll, S. A., Laroui, H., Kolachala, V. L., Wang, L., Garg, P., Denning, T. L., Gewirtz, A. T., Merlin, D., & Sitaraman, S. V. (2012) · Digestive and Liver Disease · doi:10.1016/j.dld.2012.05.013 · Cited by 12
Otsuguro, K., Tomonari, Y., Otsuka, S., Yamaguchi, S., Kon, Y., & Ito, S. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.05.035 · Cited by 8
Adenosine as a probing tool for the mechanistic study of acupuncture treatment
Wang, J., Li, H., Zhang, L., Ma, C., Wang, J., Lai, X., & Zhou, S. (2014) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12304 · Cited by 7
Cited by
Pharmacology of Adenosine Receptors: The State of the Art
Borea, P. A., Gessi, S., Merighi, S., Vincenzi, F., & Varani, K. (2018) · Physiological Reviews · doi:10.1152/physrev.00049.2017 · Cited by 783
Self-citationHow does adenosine control neuronal dysfunction and neurodegeneration?
Cunha, R. A. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13724 · Cited by 441
Purinergic Signalling: Therapeutic Developments
Burnstock, G. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00661 · Cited by 398
Adenosine Metabolism: Emerging Concepts for Cancer Therapy
Boison, D., & Yegutkin, G. G. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.10.007 · Cited by 336
Colangelo, M. T., Galli, C., & Guizzardi, S. (2020) · Regenerative Medicine · doi:10.2217/rme-2019-0118 · Cited by 59
Metadata
- Authors
- Borea, P. A., Gessi, S., Merighi, S., & Varani, K.
- Venue
- Trends in Pharmacological Sciences
- Publisher
- Elsevier BV
- Published
- 2016-06
- Volume
- 37
- Issue
- 6
- Pages
- 419-434
- ISSN
- 0165-6147 (ISSN-L)
- OpenAlex
- W2290031963
- Cited by
- 311
- References
- 131
- FWCI
- 2.32
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.